Monday, October 16, 2017
New Therapies for Managing Multiple Sclerosis: From Stem Cells to Exercise
Proclamation of Brain Health Awareness Week with Ottawa City Councillor Jean Cloutier, Alta Vista Ward
Canada has the highest rate of multiple sclerosis (MS) in with world, with approximately one in every 340 Canadians affected by this disease. Although the exact cause of MS is unknown, the disease is believed to involve immune-mediated processes that result in damage to the central nervous system. MS can result in a variety of physical, mental and emotional symptoms, and it is experienced differently by each individual. There is currently no cure for MS, but researchers continue to explore new strategies for treating this disease and managing its consequences.
Please join the researchers and clinicians of the uOBMRI Multiple Sclerosis Research Group as they highlight some of these novel approaches and current advancements in MS care.
Hosted by Dr. Mark Freedman, MS Clinic Director, senior scientist at The Ottawa Hospital Research Institute, and Professor of Neurology at the University of Ottawa, and Dr. Lara Pilutti of the Faculty of Health Sciences at the University of Ottawa, the evening will explore innovative treatments for MS ranging from stem cell transplantation to exercise rehabilitation. We will discuss the potential disease-modifying and symptomatic benefits of these strategies and future directions in MS treatment. Come join us to learn more about the exciting advancements in MS research here in Ottawa.
Tuesday, October 17, 2017
Mr. Hockey and Stem Cells: Getting Canada in the Game
Looking to discover a safe and effective stem cell therapy for stroke
How can Canada, with its rich history and expertise in stem cells, lead the global race to discover a safe and effective stem cell therapy for stroke?
This dynamic discussion will feature the perspectives one of Canada’s leading stroke researchers (Dr. Dale Corbett), a leading stroke clinical researcher and neurologist (Dr. Dar Dowlatshahi), and one of the world’s leading stem cell clinical researchers who personally visited, with W5, the clinic in Mexico where Gordie Howe received his stem cell therapy (Dr. Duncan Stewart).
Wednesday, October 18, 2017
Alzheimer's disease: The Challenge of the Next Decade
There are currently over 500,000 Canadians suffering from Alzheimer’s disease (AD) or another form of dementia, and the number is steadily increasing every day. By the year 2050 an estimated 1.5 million people in Canada, and an additional 150 million people worldwide, will suffer from AD. Moreover, these estimates do not include the countless silent sufferers dealing with the social, emotional and financial turmoil associated with caring for loved ones stricken by this disease. AD progresses slowly, first robbing sufferers of their short-term memories, like where they left their keys, then wiping their long-term memories from their brains, like the names of their loved ones, and finally taking away their ability to do simple daily tasks, like taking a shower.
There is currently no cure for AD and little progress has been made to develop new treatments. Therefore, there is an urgent need for new ideas that can lead to new therapeutic strategies aimed at key features of the disease. Since there are no curative medications, it is crucial to identify early the candidates that could potentially develop this terrible disease.
We have invited a panel of experts to discuss the impact of Alzheimer on the individuals and their families and on the society as a whole. Social worker, neuropsychologist, lawyer, physician and importantly a care giver will share their expertise and experience with this pathology. These experts will answer any question from the audience. The recent clinical studies give hope that in a near future, there might be more efficient treatment. The data of these studies will be also discussed. We hope to provide useful information for the public.
Thursday, October 19, 2017
The uOBMRI-Rowan's Legacy Symposium
A forum to enhance concussion awareness and education
The uOBMRI-Rowan's Legacy Symposium is a collaborative event seeking to enhance concussion education and awareness in the Ottawa community. The event is designed to educate athletes, coaches, parents, and the general public on the impact of concussions, as well as present current concussion and head trauma research. The goal of the event is to create general awareness regarding head trauma and to answer popular questions, including what to do if your child has a concussion.
This symposium will feature researchers and health care professionals who will provide information on leading advances in concussion care and research. In this regard, Dr. Shawn Marshall will provide information on the status of current treatment for concussion injury in adults while Dr. Roger Zemek will describe leading research on pediatric concussion injury.
Additionally, the event will feature an athlete panel where former and current elite athletes (professional, semi-professional, and university) can share how concussions impacted their education and playing careers. This event is brought to the Ottawa community through a partnership between the University of Ottawa Brain and Mind Research Institute and the Concussion Legacy Foundation Canada in honor of the late Rowan Stringer of Nepean, Ontario and her family.
Friday, October 20, 2017
New Inroads in Parkinson’s Research: The Gut-Brain Connection
With CTV News Ottawa Sports Director -Terry Marcotte
Our understanding of the causes of Parkinson's disease has evolved remarkably over the past decade. Once thought to be a disease confined to a specific region of the brain, recent research has demonstrated that the disease process extends to multiple organ systems. Specifically, there is growing evidence that the disease may begin in the gastrointestinal system. Not only does this provide a window of opportunity for therapeutic intervention, but it implicates gut micro-organisms (the microbiome) and gut immunity as disease-promoting factors. Join Dr. John Woulfe, who will provide an overview of this exciting new research and discuss his own research in this area.
Also join Dr. David Grimes, Division Head and Chief, Division of Neurology, The Ottawa Hospital and uOttawa who will provide an update on other successes in Parkinson's Research at the uOBMRI and The Ottawa Hospital including our Integrated Parkinson’s Care Network and celebrating our 2017 Fellowship awardees.